Solventum Corporation ( SOLV) - Key Metrics
SOLV Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q1 | $11.92 | $0.79 | $0.17 | -$0.46 |
| 2024Q4 | $11.96 | $0.17 | $1.26 | $0.53 |
| 2024Q3 | $12.01 | $0.70 | $0.97 | $0.44 |
| 2024Q2 | $12.02 | $0.51 | $2.05 | $1.71 |
| 2024Q1 | $11.67 | $1.37 | $2.56 | $1.97 |
SOLV Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q1 | ? | 24.10 |
| 2024Q4 | ? | 95.46 |
| 2024Q3 | ? | 24.77 |
| 2024Q2 | ? | 25.03 |
| 2024Q1 | ? | 12.59 |
SOLV
Price: $73.80
52 week price:
Earnings Per Share: 2.17 USD
P/E Ratio: 34.21
Exchange: NYQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Market Capitalization: 12.8 billion